During the last session, Zenas Biopharma Inc (NASDAQ:ZBIO)’s traded shares were 0.13 million. At the end of the trading day, the stock’s price was $9.31, reflecting an intraday loss of -3.82% or -$0.37. The 52-week high for the ZBIO share is $26.25, that puts it down -181.95 from that peak though still a striking 37.38% gain since the share price plummeted to a 52-week low of $5.83. The company’s market capitalization is $389.47M, and the average intraday trading volume over the past 10 days was 0.25 million shares, and the average trade volume was 198.08K shares over the past three months.

Zenas Biopharma Inc (NASDAQ:ZBIO) trade information

Zenas Biopharma Inc (ZBIO) registered a -3.82% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -3.82% in intraday trading to $9.31, hitting a weekly high. The stock’s 5-day price performance is -23.12%, and it has moved by -15.44% in 30 days. The short interest in Zenas Biopharma Inc (NASDAQ:ZBIO) is 4.86 million shares and it means that shorts have 36.23 day(s) to cover.

The consensus price target of analysts on Wall Street is $35, which implies an increase of 73.4% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $35 and $35 respectively. As a result, ZBIO is trading at a discount of -275.94% off the target high and -275.94% off the low.

While earnings are projected to return 65.55% in 2025, the next five years will return 31.82% per annum.

ZBIO Dividends

Zenas Biopharma Inc is due to release its next quarterly earnings on 2025-May-15. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Zenas Biopharma Inc (NASDAQ:ZBIO)’s Major holders

Zenas Biopharma Inc insiders own 21.20% of total outstanding shares while institutional holders control 74.88%, with the float percentage being 95.02%.